-
1
-
-
79151478555
-
Type 2 diabetes as an inflammatory disease
-
Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 2011, 11:98-107.
-
(2011)
Nat. Rev. Immunol.
, vol.11
, pp. 98-107
-
-
Donath, M.Y.1
Shoelson, S.E.2
-
2
-
-
33845866857
-
Inflammation and metabolic disorders
-
Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
-
(2006)
Nature
, vol.444
, pp. 860-867
-
-
Hotamisligil, G.S.1
-
3
-
-
79151484704
-
Adipokines in inflammation and metabolic disease
-
Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11:85-97.
-
(2011)
Nat. Rev. Immunol.
, vol.11
, pp. 85-97
-
-
Ouchi, N.1
Parker, J.L.2
Lugus, J.J.3
Walsh, K.4
-
4
-
-
36048991085
-
Physiology. An integrative view of obesity
-
Wisse B.E., Kim F., Schwartz M.W. Physiology. An integrative view of obesity. Science 2007, 318:928-929.
-
(2007)
Science
, vol.318
, pp. 928-929
-
-
Wisse, B.E.1
Kim, F.2
Schwartz, M.W.3
-
5
-
-
33645523067
-
Prevalence of overweight and obesity in the United States, 1999-2004
-
Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. J. Am. Med. Assoc. 2006, 295:1549-1555.
-
(2006)
J. Am. Med. Assoc.
, vol.295
, pp. 1549-1555
-
-
Ogden, C.L.1
Carroll, M.D.2
Curtin, L.R.3
McDowell, M.A.4
Tabak, C.J.5
Flegal, K.M.6
-
6
-
-
84859089427
-
Lifestyle change and mobility in obese adults with type 2 diabetes
-
Rejeski W.J., Ip E.H., Bertoni A.G., Bray G.A., Evans G., Gregg E.W., Zhang Q. Lifestyle change and mobility in obese adults with type 2 diabetes. N. Engl. J. Med. 2012, 366:1209-1217.
-
(2012)
N. Engl. J. Med.
, vol.366
, pp. 1209-1217
-
-
Rejeski, W.J.1
Ip, E.H.2
Bertoni, A.G.3
Bray, G.A.4
Evans, G.5
Gregg, E.W.6
Zhang, Q.7
-
7
-
-
78649747039
-
Body-mass index and mortality among 1.46 million white adults
-
Berrington de Gonzalez A., Hartge P., Cerhan J.R., Flint A.J., Hannan L., MacInnis R.J., Moore S.C., Tobias G.S., Anton-Culver H., Freeman L.B., Beeson W.L., Clipp S.L., English D.R., Folsom A.R., Freedman D.M., Giles G., Hakansson N., Henderson K.D., Hoffman-Bolton J., Hoppin J.A., Koenig K.L., Lee I.M., Linet M.S., Park Y., Pocobelli G., Schatzkin A., Sesso H.D., Weiderpass E., Willcox B.J., Wolk A., Zeleniuch-Jacquotte A., Willett W.C., Thun M.J. Body-mass index and mortality among 1.46 million white adults. N. Engl. J. Med. 2010, 363:2211-2219.
-
(2010)
N. Engl. J. Med.
, vol.363
, pp. 2211-2219
-
-
Berrington de Gonzalez, A.1
Hartge, P.2
Cerhan, J.R.3
Flint, A.J.4
Hannan, L.5
MacInnis, R.J.6
Moore, S.C.7
Tobias, G.S.8
Anton-Culver, H.9
Freeman, L.B.10
Beeson, W.L.11
Clipp, S.L.12
English, D.R.13
Folsom, A.R.14
Freedman, D.M.15
Giles, G.16
Hakansson, N.17
Henderson, K.D.18
Hoffman-Bolton, J.19
Hoppin, J.A.20
Koenig, K.L.21
Lee, I.M.22
Linet, M.S.23
Park, Y.24
Pocobelli, G.25
Schatzkin, A.26
Sesso, H.D.27
Weiderpass, E.28
Willcox, B.J.29
Wolk, A.30
Zeleniuch-Jacquotte, A.31
Willett, W.C.32
Thun, M.J.33
more..
-
8
-
-
68349150756
-
CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity
-
Nishimura S., Manabe I., Nagasaki M., Eto K., Yamashita H., Ohsugi M., Otsu M., Hara K., Ueki K., Sugiura S., Yoshimura K., Kadowaki T., Nagai R. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 2009, 15:914-920.
-
(2009)
Nat. Med.
, vol.15
, pp. 914-920
-
-
Nishimura, S.1
Manabe, I.2
Nagasaki, M.3
Eto, K.4
Yamashita, H.5
Ohsugi, M.6
Otsu, M.7
Hara, K.8
Ueki, K.9
Sugiura, S.10
Yoshimura, K.11
Kadowaki, T.12
Nagai, R.13
-
9
-
-
69949150673
-
A crucial role for adipose tissue p53 in the regulation of insulin resistance
-
Minamino T., Orimo M., Shimizu I., Kunieda T., Yokoyama M., Ito T., Nojima A., Nabetani A., Oike Y., Matsubara H., Ishikawa F., Komuro I. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat. Med. 2009, 15:1082-1087.
-
(2009)
Nat. Med.
, vol.15
, pp. 1082-1087
-
-
Minamino, T.1
Orimo, M.2
Shimizu, I.3
Kunieda, T.4
Yokoyama, M.5
Ito, T.6
Nojima, A.7
Nabetani, A.8
Oike, Y.9
Matsubara, H.10
Ishikawa, F.11
Komuro, I.12
-
10
-
-
0027459878
-
Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance
-
Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
-
(1993)
Science
, vol.259
, pp. 87-91
-
-
Hotamisligil, G.S.1
Shargill, N.S.2
Spiegelman, B.M.3
-
11
-
-
33748750917
-
Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance
-
Kamei N., Tobe K., Suzuki R., Ohsugi M., Watanabe T., Kubota N., Ohtsuka-Kowatari N., Kumagai K., Sakamoto K., Kobayashi M., Yamauchi T., Ueki K., Oishi Y., Nishimura S., Manabe I., Hashimoto H., Ohnishi Y., Ogata H., Tokuyama K., Tsunoda M., Ide T., Murakami K., Nagai R., Kadowaki T. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J. Biol. Chem. 2006, 281:26602-26614.
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 26602-26614
-
-
Kamei, N.1
Tobe, K.2
Suzuki, R.3
Ohsugi, M.4
Watanabe, T.5
Kubota, N.6
Ohtsuka-Kowatari, N.7
Kumagai, K.8
Sakamoto, K.9
Kobayashi, M.10
Yamauchi, T.11
Ueki, K.12
Oishi, Y.13
Nishimura, S.14
Manabe, I.15
Hashimoto, H.16
Ohnishi, Y.17
Ogata, H.18
Tokuyama, K.19
Tsunoda, M.20
Ide, T.21
Murakami, K.22
Nagai, R.23
Kadowaki, T.24
more..
-
12
-
-
0348230958
-
Obesity is associated with macrophage accumulation in adipose tissue
-
Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112:1796-1808.
-
(2003)
J. Clin. Invest.
, vol.112
, pp. 1796-1808
-
-
Weisberg, S.P.1
McCann, D.2
Desai, M.3
Rosenbaum, M.4
Leibel, R.L.5
Ferrante, A.W.6
-
15
-
-
37849047917
-
Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options
-
Witteles R.M., Fowler M.B. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J. Am. Coll. Cardiol. 2008, 51:93-102.
-
(2008)
J. Am. Coll. Cardiol.
, vol.51
, pp. 93-102
-
-
Witteles, R.M.1
Fowler, M.B.2
-
16
-
-
77951773194
-
Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents
-
Shimizu I., Minamino T., Toko H., Okada S., Ikeda H., Yasuda N., Tateno K., Moriya J., Yokoyama M., Nojima A., Koh G.Y., Akazawa H., Shiojima I., Kahn C.R., Abel E.D., Komuro I. Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents. J. Clin. Invest. 2010, 120:1506-1514.
-
(2010)
J. Clin. Invest.
, vol.120
, pp. 1506-1514
-
-
Shimizu, I.1
Minamino, T.2
Toko, H.3
Okada, S.4
Ikeda, H.5
Yasuda, N.6
Tateno, K.7
Moriya, J.8
Yokoyama, M.9
Nojima, A.10
Koh, G.Y.11
Akazawa, H.12
Shiojima, I.13
Kahn, C.R.14
Abel, E.D.15
Komuro, I.16
-
17
-
-
84855453214
-
P53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure
-
Shimizu I., Yoshida Y., Katsuno T., Tateno K., Okada S., Moriya J., Yokoyama M., Nojima A., Ito T., Zechner R., Komuro I., Kobayashi Y., Minamino T. p53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure. Cell Metab. 2012, 15:51-64.
-
(2012)
Cell Metab.
, vol.15
, pp. 51-64
-
-
Shimizu, I.1
Yoshida, Y.2
Katsuno, T.3
Tateno, K.4
Okada, S.5
Moriya, J.6
Yokoyama, M.7
Nojima, A.8
Ito, T.9
Zechner, R.10
Komuro, I.11
Kobayashi, Y.12
Minamino, T.13
-
18
-
-
33845914986
-
Mechanisms linking obesity with cardiovascular disease
-
Van Gaal L.F., Mertens I.L., De Block C.E. Mechanisms linking obesity with cardiovascular disease. Nature 2006, 444:875-880.
-
(2006)
Nature
, vol.444
, pp. 875-880
-
-
Van Gaal, L.F.1
Mertens, I.L.2
De Block, C.E.3
-
19
-
-
81455135755
-
Childhood adiposity, adult adiposity, and cardiovascular risk factors
-
Juonala M., Magnussen C.G., Berenson G.S., Venn A., Burns T.L., Sabin M.A., Srinivasan S.R., Daniels S.R., Davis P.H., Chen W., Sun C., Cheung M., Viikari J.S., Dwyer T., Raitakari O.T. Childhood adiposity, adult adiposity, and cardiovascular risk factors. N. Engl. J. Med. 2011, 365:1876-1885.
-
(2011)
N. Engl. J. Med.
, vol.365
, pp. 1876-1885
-
-
Juonala, M.1
Magnussen, C.G.2
Berenson, G.S.3
Venn, A.4
Burns, T.L.5
Sabin, M.A.6
Srinivasan, S.R.7
Daniels, S.R.8
Davis, P.H.9
Chen, W.10
Sun, C.11
Cheung, M.12
Viikari, J.S.13
Dwyer, T.14
Raitakari, O.T.15
-
20
-
-
33846121333
-
Vascular cell senescence: contribution to atherosclerosis
-
Minamino T., Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ. Res. 2007, 100:15-26.
-
(2007)
Circ. Res.
, vol.100
, pp. 15-26
-
-
Minamino, T.1
Komuro, I.2
-
21
-
-
54849382700
-
Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes
-
Minamino T., Komuro I. Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes. Nat. Clin. Pract. Cardiovasc. Med. 2008, 5:637-648.
-
(2008)
Nat. Clin. Pract. Cardiovasc. Med.
, vol.5
, pp. 637-648
-
-
Minamino, T.1
Komuro, I.2
-
22
-
-
0027109075
-
Cancer. p53, guardian of the genome
-
Lane D.P. Cancer. p53, guardian of the genome. Nature 1992, 358:15-16.
-
(1992)
Nature
, vol.358
, pp. 15-16
-
-
Lane, D.P.1
-
23
-
-
33745713432
-
P53 and metabolism: inside the TIGAR
-
Green D.R., Chipuk J.E. p53 and metabolism: inside the TIGAR. Cell 2006, 126:30-32.
-
(2006)
Cell
, vol.126
, pp. 30-32
-
-
Green, D.R.1
Chipuk, J.E.2
-
24
-
-
0035856949
-
Insulin signalling and the regulation of glucose and lipid metabolism
-
Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
-
(2001)
Nature
, vol.414
, pp. 799-806
-
-
Saltiel, A.R.1
Kahn, C.R.2
-
25
-
-
33750374137
-
The twentieth century struggle to decipher insulin signalling
-
Cohen P. The twentieth century struggle to decipher insulin signalling. Nat. Rev. Mol. Cell Biol. 2006, 7:867-873.
-
(2006)
Nat. Rev. Mol. Cell Biol.
, vol.7
, pp. 867-873
-
-
Cohen, P.1
-
26
-
-
0037130175
-
Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration
-
Lin S.J., Kaeberlein M., Andalis A.A., Sturtz L.A., Defossez P.A., Culotta V.C., Fink G.R., Guarente L. Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration. Nature 2002, 418:344-348.
-
(2002)
Nature
, vol.418
, pp. 344-348
-
-
Lin, S.J.1
Kaeberlein, M.2
Andalis, A.A.3
Sturtz, L.A.4
Defossez, P.A.5
Culotta, V.C.6
Fink, G.R.7
Guarente, L.8
-
27
-
-
0034703217
-
Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae
-
Lin S.J., Defossez P.A., Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 2000, 289:2126-2128.
-
(2000)
Science
, vol.289
, pp. 2126-2128
-
-
Lin, S.J.1
Defossez, P.A.2
Guarente, L.3
-
28
-
-
28844469898
-
Increase in activity during calorie restriction requires Sirt1
-
Chen D., Steele A.D., Lindquist S., Guarente L. Increase in activity during calorie restriction requires Sirt1. Science 2005, 310:1641.
-
(2005)
Science
, vol.310
, pp. 1641
-
-
Chen, D.1
Steele, A.D.2
Lindquist, S.3
Guarente, L.4
-
29
-
-
77951176737
-
Extending healthy life span-from yeast to humans
-
Fontana L., Partridge L., Longo V.D. Extending healthy life span-from yeast to humans. Science 2010, 328:321-326.
-
(2010)
Science
, vol.328
, pp. 321-326
-
-
Fontana, L.1
Partridge, L.2
Longo, V.D.3
-
30
-
-
0037470501
-
The endocrine regulation of aging by insulin-like signals
-
Tatar M., Bartke A., Antebi A. The endocrine regulation of aging by insulin-like signals. Science 2003, 299:1346-1351.
-
(2003)
Science
, vol.299
, pp. 1346-1351
-
-
Tatar, M.1
Bartke, A.2
Antebi, A.3
-
31
-
-
70349669095
-
Ribosomal protein S6 kinase 1 signaling regulates mammalian life span
-
Selman C., Tullet J.M., Wieser D., Irvine E., Lingard S.J., Choudhury A.I., Claret M., Al-Qassab H., Carmignac D., Ramadani F., Woods A., Robinson I.C., Schuster E., Batterham R.L., Kozma S.C., Thomas G., Carling D., Okkenhaug K., Thornton J.M., Partridge L., Gems D., Withers D.J. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 2009, 326:140-144.
-
(2009)
Science
, vol.326
, pp. 140-144
-
-
Selman, C.1
Tullet, J.M.2
Wieser, D.3
Irvine, E.4
Lingard, S.J.5
Choudhury, A.I.6
Claret, M.7
Al-Qassab, H.8
Carmignac, D.9
Ramadani, F.10
Woods, A.11
Robinson, I.C.12
Schuster, E.13
Batterham, R.L.14
Kozma, S.C.15
Thomas, G.16
Carling, D.17
Okkenhaug, K.18
Thornton, J.M.19
Partridge, L.20
Gems, D.21
Withers, D.J.22
more..
-
32
-
-
13944269223
-
The plasticity of aging: insights from long-lived mutants
-
Kenyon C. The plasticity of aging: insights from long-lived mutants. Cell 2005, 120:449-460.
-
(2005)
Cell
, vol.120
, pp. 449-460
-
-
Kenyon, C.1
-
33
-
-
0035815414
-
Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein
-
Clancy D.J., Gems D., Harshman L.G., Oldham S., Stocker H., Hafen E., Leevers S.J., Partridge L. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 2001, 292:104-106.
-
(2001)
Science
, vol.292
, pp. 104-106
-
-
Clancy, D.J.1
Gems, D.2
Harshman, L.G.3
Oldham, S.4
Stocker, H.5
Hafen, E.6
Leevers, S.J.7
Partridge, L.8
-
34
-
-
9644278037
-
Insulin regulation of heart function in aging fruit flies
-
Wessells R.J., Fitzgerald E., Cypser J.R., Tatar M., Bodmer R. Insulin regulation of heart function in aging fruit flies. Nat. Genet. 2004, 36:1275-1281.
-
(2004)
Nat. Genet.
, vol.36
, pp. 1275-1281
-
-
Wessells, R.J.1
Fitzgerald, E.2
Cypser, J.R.3
Tatar, M.4
Bodmer, R.5
-
35
-
-
33947520124
-
P53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload
-
Sano M., Minamino T., Toko H., Miyauchi H., Orimo M., Qin Y., Akazawa H., Tateno K., Kayama Y., Harada M., Shimizu I., Asahara T., Hamada H., Tomita S., Molkentin J.D., Zou Y., Komuro I. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 2007, 446:444-448.
-
(2007)
Nature
, vol.446
, pp. 444-448
-
-
Sano, M.1
Minamino, T.2
Toko, H.3
Miyauchi, H.4
Orimo, M.5
Qin, Y.6
Akazawa, H.7
Tateno, K.8
Kayama, Y.9
Harada, M.10
Shimizu, I.11
Asahara, T.12
Hamada, H.13
Tomita, S.14
Molkentin, J.D.15
Zou, Y.16
Komuro, I.17
-
36
-
-
0034213075
-
The conserved phosphoinositide 3-kinase pathway determines heart size in mice
-
Shioi T., Kang P.M., Douglas P.S., Hampe J., Yballe C.M., Lawitts J., Cantley L.C., Izumo S. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J. 2000, 19:2537-2548.
-
(2000)
EMBO J.
, vol.19
, pp. 2537-2548
-
-
Shioi, T.1
Kang, P.M.2
Douglas, P.S.3
Hampe, J.4
Yballe, C.M.5
Lawitts, J.6
Cantley, L.C.7
Izumo, S.8
-
37
-
-
0142027759
-
Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy
-
McMullen J.R., Shioi T., Zhang L., Tarnavski O., Sherwood M.C., Kang P.M., Izumo S. Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc. Natl. Acad. Sci. U S A 2003, 100:12355-12360.
-
(2003)
Proc. Natl. Acad. Sci. U S A
, vol.100
, pp. 12355-12360
-
-
McMullen, J.R.1
Shioi, T.2
Zhang, L.3
Tarnavski, O.4
Sherwood, M.C.5
Kang, P.M.6
Izumo, S.7
-
38
-
-
33646449520
-
Akt1 is required for physiological cardiac growth
-
DeBosch B., Treskov I., Lupu T.S., Weinheimer C., Kovacs A., Courtois M., Muslin A.J. Akt1 is required for physiological cardiac growth. Circulation 2006, 113:2097-2104.
-
(2006)
Circulation
, vol.113
, pp. 2097-2104
-
-
DeBosch, B.1
Treskov, I.2
Lupu, T.S.3
Weinheimer, C.4
Kovacs, A.5
Courtois, M.6
Muslin, A.J.7
-
39
-
-
23644439061
-
Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure
-
Shiojima I., Sato K., Izumiya Y., Schiekofer S., Ito M., Liao R., Colucci W.S., Walsh K. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J. Clin. Invest. 2005, 115:2108-2118.
-
(2005)
J. Clin. Invest.
, vol.115
, pp. 2108-2118
-
-
Shiojima, I.1
Sato, K.2
Izumiya, Y.3
Schiekofer, S.4
Ito, M.5
Liao, R.6
Colucci, W.S.7
Walsh, K.8
-
40
-
-
22244474634
-
Insulin resistance and risk of congestive heart failure
-
Ingelsson E., Sundstrom J., Arnlov J., Zethelius B., Lind L. Insulin resistance and risk of congestive heart failure. J. Am. Med. Assoc. 2005, 294:334-341.
-
(2005)
J. Am. Med. Assoc.
, vol.294
, pp. 334-341
-
-
Ingelsson, E.1
Sundstrom, J.2
Arnlov, J.3
Zethelius, B.4
Lind, L.5
-
41
-
-
0034812816
-
Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up
-
Arnlov J., Lind L., Zethelius B., Andren B., Hales C.N., Vessby B., Lithell H. Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up. Am. Heart J. 2001, 142:720-724.
-
(2001)
Am. Heart J.
, vol.142
, pp. 720-724
-
-
Arnlov, J.1
Lind, L.2
Zethelius, B.3
Andren, B.4
Hales, C.N.5
Vessby, B.6
Lithell, H.7
-
42
-
-
0347753367
-
The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy
-
Nikolaidis L.A., Sturzu A., Stolarski C., Elahi D., Shen Y.T., Shannon R.P. The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy. Cardiovasc. Res. 2004, 61:297-306.
-
(2004)
Cardiovasc. Res.
, vol.61
, pp. 297-306
-
-
Nikolaidis, L.A.1
Sturzu, A.2
Stolarski, C.3
Elahi, D.4
Shen, Y.T.5
Shannon, R.P.6
-
43
-
-
67650531390
-
Sympathetic nervous system activation in human heart failure: clinical implications of an updated model
-
Floras J.S. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J. Am. Coll. Cardiol. 2009, 54:375-385.
-
(2009)
J. Am. Coll. Cardiol.
, vol.54
, pp. 375-385
-
-
Floras, J.S.1
-
44
-
-
48449083426
-
Saturated fatty acids modulate cell response to DNA damage: implication for their role in tumorigenesis
-
Zeng L., Wu G.Z., Goh K.J., Lee Y.M., Ng C.C., You A.B., Wang J., Jia D., Hao A., Yu Q., Li B. Saturated fatty acids modulate cell response to DNA damage: implication for their role in tumorigenesis. PLoS One 2008, 3:e2329.
-
(2008)
PLoS One
, vol.3
-
-
Zeng, L.1
Wu, G.Z.2
Goh, K.J.3
Lee, Y.M.4
Ng, C.C.5
You, A.B.6
Wang, J.7
Jia, D.8
Hao, A.9
Yu, Q.10
Li, B.11
-
45
-
-
0034104565
-
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group
-
Hjalmarson A., Goldstein S., Fagerberg B., Wedel H., Waagstein F., Kjekshus J., Wikstrand J., El Allaf D., Vitovec J., Aldershvile J., Halinen M., Dietz R., Neuhaus K.L., Janosi A., Thorgeirsson G., Dunselman P.H., Gullestad L., Kuch J., Herlitz J., Rickenbacher P., Ball S., Gottlieb S., Deedwania P. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. J. Am. Med. Assoc. 2000, 283:1295-1302.
-
(2000)
J. Am. Med. Assoc.
, vol.283
, pp. 1295-1302
-
-
Hjalmarson, A.1
Goldstein, S.2
Fagerberg, B.3
Wedel, H.4
Waagstein, F.5
Kjekshus, J.6
Wikstrand, J.7
El Allaf, D.8
Vitovec, J.9
Aldershvile, J.10
Halinen, M.11
Dietz, R.12
Neuhaus, K.L.13
Janosi, A.14
Thorgeirsson, G.15
Dunselman, P.H.16
Gullestad, L.17
Kuch, J.18
Herlitz, J.19
Rickenbacher, P.20
Ball, S.21
Gottlieb, S.22
Deedwania, P.23
more..
-
46
-
-
0036481456
-
Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies-CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol Study
-
Leizorovicz A., Lechat P., Cucherat M., Bugnard F. Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies-CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol Study. Am. Heart J. 2002, 143:301-307.
-
(2002)
Am. Heart J.
, vol.143
, pp. 301-307
-
-
Leizorovicz, A.1
Lechat, P.2
Cucherat, M.3
Bugnard, F.4
-
47
-
-
0037159310
-
Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study
-
Packer M., Fowler M.B., Roecker E.B., Coats A.J., Katus H.A., Krum H., Mohacsi P., Rouleau J.L., Tendera M., Staiger C., Holcslaw T.L., Amann-Zalan I., DeMets D.L. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002, 106:2194-2199.
-
(2002)
Circulation
, vol.106
, pp. 2194-2199
-
-
Packer, M.1
Fowler, M.B.2
Roecker, E.B.3
Coats, A.J.4
Katus, H.A.5
Krum, H.6
Mohacsi, P.7
Rouleau, J.L.8
Tendera, M.9
Staiger, C.10
Holcslaw, T.L.11
Amann-Zalan, I.12
DeMets, D.L.13
-
48
-
-
34250308746
-
Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)
-
Torp-Pedersen C., Metra M., Charlesworth A., Spark P., Lukas M.A., Poole-Wilson P.A., Swedberg K., Cleland J.G., Di Lenarda A., Remme W.J., Scherhag A. Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET). Heart 2007, 93:968-973.
-
(2007)
Heart
, vol.93
, pp. 968-973
-
-
Torp-Pedersen, C.1
Metra, M.2
Charlesworth, A.3
Spark, P.4
Lukas, M.A.5
Poole-Wilson, P.A.6
Swedberg, K.7
Cleland, J.G.8
Di Lenarda, A.9
Remme, W.J.10
Scherhag, A.11
-
49
-
-
0037066014
-
Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo
-
Asakawa M., Takano H., Nagai T., Uozumi H., Hasegawa H., Kubota N., Saito T., Masuda Y., Kadowaki T., Komuro I. Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo. Circulation 2002, 105:1240-1246.
-
(2002)
Circulation
, vol.105
, pp. 1240-1246
-
-
Asakawa, M.1
Takano, H.2
Nagai, T.3
Uozumi, H.4
Hasegawa, H.5
Kubota, N.6
Saito, T.7
Masuda, Y.8
Kadowaki, T.9
Komuro, I.10
-
50
-
-
11144344187
-
PPAR-gamma agonist rosiglitazone ameliorates ventricular dysfunction in experimental chronic mitral regurgitation
-
Nemoto S., Razeghi P., Ishiyama M., De Freitas G., Taegtmeyer H., Carabello B.A. PPAR-gamma agonist rosiglitazone ameliorates ventricular dysfunction in experimental chronic mitral regurgitation. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H77-H82.
-
(2005)
Am. J. Physiol. Heart Circ. Physiol.
, vol.288
-
-
Nemoto, S.1
Razeghi, P.2
Ishiyama, M.3
De Freitas, G.4
Taegtmeyer, H.5
Carabello, B.A.6
-
51
-
-
67149146438
-
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
-
Home P.D., Pocock S.J., Beck-Nielsen H., Curtis P.S., Gomis R., Hanefeld M., Jones N.P., Komajda M., McMurray J.J. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet 2009, 373:2125-2135.
-
(2009)
Lancet
, vol.373
, pp. 2125-2135
-
-
Home, P.D.1
Pocock, S.J.2
Beck-Nielsen, H.3
Curtis, P.S.4
Gomis, R.5
Hanefeld, M.6
Jones, N.P.7
Komajda, M.8
McMurray, J.J.9
|